Evidence map›Paper›PMID 35928876›Full record

ArticleFrontiers in oncology2022

Interplay Between Immune and Cancer-Associated Fibroblasts: A Path to Target Metalloproteinases in Penile Cancer.

Sarah Santiloni Cury, Hellen Kuasne, Jeferson Dos Santos Souza, Juan Jose Moyano Muñoz, Jeyson Pereira da Silva, Ademar Lopes, Cristovam Scapulatempo-Neto, Eliney Ferreira Faria, Jean-Marie Delaissé, Fabio Albuquerque Marchi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Inflammation in Penile Squamous Cell Carcinoma: A Comprehensive Review.International journal of molecular sciences · 2025
    Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Sarah Santiloni CuryDepartment of Clinical Genetics, University Hospital of Southern Denmark, Vejle, Denmark.
Hellen KuasneDepartment of Clinical Genetics, University Hospital of Southern Denmark, Vejle, Denmark.
Jeferson Dos Santos SouzaDepartment of Structural and Functional Biology, São Paulo State University (UNESP), Botucatu, Brazil.
Juan Jose Moyano MuñozInternational Research Center (CIPE), A. C. Camargo Cancer Center, São Paulo, Brazil.
Jeyson Pereira da SilvaInternational Research Center (CIPE), A. C. Camargo Cancer Center, São Paulo, Brazil.
Ademar LopesPelvic Surgery Department, A. C. Camargo Cancer Center, São Paulo, Brazil.
Cristovam Scapulatempo-NetoMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
Eliney Ferreira FariaMolecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
Jean-Marie DelaisséClinical Cell Biology, Lillebaelt Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
Fabio Albuquerque MarchiInternational Research Center (CIPE), A. C. Camargo Cancer Center, São Paulo, Brazil.
Silvia Regina RogattoDepartment of Clinical Genetics, University Hospital of Southern Denmark, Vejle, Denmark.
AC Camargo Hospital · BRUniversidade Estadual Paulista (Unesp) · BRDASA (Brazil)Hospital Felício Rocho · BRLillebaelt Hospital · DKUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular matrix (ECM) remodeling and inflammation have been reported in penile carcinomas (PeCa). However, the cell types and cellular crosstalk involved in PeCa are unexplored. We aimed to characterize the complexity of cells and pathways involved in the tumor microenvironment (TME) in PeCa and propose target molecules associated with the TME. We first investigated the prognostic impact of cell types with a secretory profile to identify drug targets that modulate TME-enriched cells. The secretome analysis using the PeCa transcriptome revealed the enrichment of inflammation and extracellular matrix pathways. Twenty-three secreted factors were upregulated, mainly collagens and matrix metalloproteinases (MMPs). The deregulation of collagens and MMPs was confirmed by Quantitative reverse transcription - polymerase chain reaction (RT-qPCR). Further, the deconvolution method (digital cytometry) of the bulk samples revealed a high proportion of macrophages and dendritic cells (DCs) and B cells. Increased DCs and B cells were associated with better survival. A high proportion of cancer-associated fibroblasts (CAFs) was observed in low-survival patients. Patients with increased CAFs had decreased immune cell proportions. The treatment with the MMP inhibitor GM6001 in CAF cells derived from PeCa resulted in altered cell viability. We reported a crosstalk between immune cells and CAFs, and the proportion of these cell populations was associated with prognosis. We demonstrate that a drug targeting MMPs modulates CAFs, expanding the therapeutic options of PeCa.

Indexed as

cancer-associated fibroblastspenile cancerresponse to therapysecretometranscriptome

Identifiers

PMID35928876
PMCPMC9343588
OpenAlexW4285796579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.